Todd C Brady Aldeyra Therapeutics, Inc. (ALDX) insider trading activity
Todd C Brady is President and CEO of Aldeyra Therapeutics, Inc.. Currently has a direct ownership of 1.47 Million shares of ALDX, which is worth approximately $7.27 Million. The most recent transaction as insider was on Mar 12, 2024, when has been sold 85,324 shares (Common Stock) at a price of $3.05 per share, resulting in proceeds of $260,238. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.47M
0%
3M change
11.07%
12M change
Total Value Held
$7.27 Million
Todd C Brady Transaction History
Also insider at
TCB
Todd C Brady
President and CEO
Lexington, MA